Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.
Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.